Home > M&A deals 2004 > Ampersand Capital Partners and NMT Capital (Nexus) invest in Magellan Biosciences, Inc.
Venture · Test/Measurement Equipment · October 2004

Ampersand Capital Partners and NMT Capital (Nexus) invest in Magellan Biosciences, Inc.

On October 19, 2004, Ampersand Capital Partners and NMT Capital (Nexus) invested in Magellan Biosciences, Inc., a test/measurement equipment company in Massachusetts, United States.

Deal at a glance

AnnouncedOctober 19, 2004 TypeVenture TargetMagellan Biosciences, Inc. Buyers Ampersand Capital Partners
NMT Capital (Nexus)
SectorTest/Measurement Equipment LocationMassachusetts, United States ValueNot disclosed

Target company

Magellan Biosciences, Inc.
Massachusetts, United States
Test/Measurement Equipmentsector
-founded
Activestatus
View the company profile →

Buyers (2)

Private equity firm · 76 deals on record
Private equity firm · 22 deals on record
  • 1st transaction for the lead buyer in test/measurement equipment
  • 6th transaction in United States
76deals, all time
3in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Syft Technologies Ltd.Same lead buyer · Apr 2022
BioEcho Life Sciences GmbHSame lead buyer · Mar 2022
McMurray Technical ServicesSame sector and country · Aug 2026
CPI International, Inc.Same sector and country · Oct 2022
Thermal Concepts, Inc.Same sector and country · May 2022

Questions about this deal

Who acquired Magellan Biosciences, Inc.?Ampersand Capital Partners and NMT Capital (Nexus) invested in Magellan Biosciences, Inc. on October 19, 2004.

What type of deal was it?It was a venture in the test/measurement equipment sector in 2004.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).